NMCPT 2026

2026 International Conference on New Models for Cancer Prevention and Treatment (NMCPT 2026) will be held during April 17-19, 2026 in Shanghai, China, with a hybrid format. 

The theme of this conference, "New Models for Cancer Prevention and Treatment", will bring together leading experts and scholars from around the world for high-level academic exchanges and the presentation of the latest scientific research. The conference will cover a broad range of topics within the field, including but not limited to: Early-onset Cancer Prevention and Control, Biomarker-Driven Precision Screening, AI-Image Fusion Screening Technology, Precision Oncology and Personalized Medicine, Immunotherapy 2.0, Targeted Therapy, Innovative Radiation and Proton Therapy.

NMCPT 2026 offers a unique platform for participants to gain insights from thought leaders, discover cutting-edge research, expand their academic networks, and collaborate on future innovations in medical science. We hope that this event will inspire new ideas, define the future direction of medical research, and foster enduring relationships across the global medical community.

Keynote Speakers

Nagy Habib

Professor, Imperial College London, UK.

Research Interests:Clinical Sciences, Oncology and Carcinogenesis, Public Health and Health Services, Paediatrics and Reproductive Medicine, Medical Biotechnology, Immunology.

Michael Thompson

Professor, University of Toronto, Canada.

Research Interests:Bioanalytical Chemistry, Clinical Diagnostics, Drug Discovery, Nanotechnology, Molecular Imaging, Systems Biology.

Daniel Falush

Professor, Chinese Academy of Sciences, China.

Research Interests:Microbiology, Gastric Cancer, Statistical Genetic Analysis of Coadaptation, Expanding Genomic Resources, Biomedical and Ecological Relevance.

Zhiling Yu

Professor, Hong Kong Baptist University, China.

Research Interests:Pharmacology of Chinese Medicines, Anti-Cancer, Anti-Inflammation, Quality Control of Decoction Pieces.

Wei Chen

Professor, XJTLU Entrepreneur College (Taicang), China.

Research Interests:Smart Chips, Sensing Technology, New Semiconductor Materials, Wearable Technology, Detection and Prevention of Diabetes and Early Cancer.

Ahmed G. Hegazi

Professor, National Research Center, Egypt.

Research Interests:Microbiology, Immunology, Natural Medicine Efficacy.

Yicheng Ni

LaboHeal Chief Oncology Expert; Professor, Zhongda Hospital Affiliated to Southeast University, China.

Research Interests:Image-guided Diagnosis and Treatment Integration, Artificial Intelligence Medical Imaging, Tumor and Cancer Treatment, Medical Robots, Targeted Therapy, Medical Imaging and Cancer Modeling.

William C. Cho

Senior Researcher, Queen Elizabeth Hospital, China.

Research Interests:High-Throughput Technologies, Biomarkers for Cancer Diagnosis, Treatment Prediction and Prognosis.

Christopher L. Antos

Associate Professor, ShanghaiTech University, China.

Research Interests:Tissue Regeneration, Immunology, Developmental Biology, Regenerative Therapy.

Andrew Teschendorff

Professor, Chinese Academy of Sciences, China.

Research Interests:Statistical Cancer Epigenomics, Cancer Systems Biology.

Call For Papers

NMCPT 2026 is calling for submissions related to cancer prevention and treatment. Abstracts will be considered for oral or poster presentation. All accepted abstracts will be included in the conference proceedings of NMCPT 2026. Selected full papers will be recommended to SCI/SSCI journals.

Example areas include but are not limited to:

  1. Early-onset Cancer Prevention and Control

    Multi-omics Genetic Risk Assessment (including epigenetics)

    Genetic Testing and Pedigree Analysis Optimization

    Biomarker-Driven Precision Screening

    AI-Image Fusion Screening Technology

    Preventive Vaccine Development

    Drug Intervention for Precancerous Lesions

    Microbiome Manipulation for Prevention

    Safety Evaluation of Chemopreventive Drugs

    Health Disparities and Resource Allocation in Prevention

    Public Health Interventions

    Liquid Biopsy and Early Detection

    Aging and Cancer Recurrence Prevention

    Behavioral Science and Health Education

  2. Cancer Drugs, Vaccines, and Drug Development

    Precision Oncology and Personalized Medicine

    Immunotherapy 2.0

    Targeted Therapy

    Combination Therapies

    Tumor Microenvironment Regulation

    Supportive Care and Integrative Oncology

    Innovations in Minimally Invasive/Robotic Surgery

    Innovative Radiation and Proton Therapy

    Management of Complications and Side Effects in Cancer Treatment

    Supportive Oncology (e.g., nutritional support, symptom management, psychological intervention, end-of-life care, etc.)

    Multi-omics and Big Data

    AI Pathology Screening and Auxiliary Diagnosis

    Wearable and Digital Technologies in Cancer Care

    Drug Delivery and Nanotechnology Applications

All submissions should be in English, follow the abstract template/full paper template, and be sent to the conference email address: contact@nmcpt.com or through 论文投稿. To avoid duplicate submissions, kindly use only one method.

Important Information

Important Dates

- Paper submission deadline: 2026-03-31

- Notification of acceptance: 2026-04-10

- Registration deadline: 2026-04-15

Conference Venue

  • 1.jpg

  • 2.jpg

  • 3.jpg

Pine City Hotel

Address: No. 8 Dong'an Road, Xuhui District, Shanghai

Traffic: Pine City Hotel enjoys a convenient location, just 140 meters from Zhaojiabang Road Station on Metro Lines 7 and 9; 6.7 km from Shanghai South Railway Station; 11.6 km from Shanghai Hongqiao International Airport.

Read More >>

Hosted by

  1. School of Public Health, Fudan University

    School of Public Health, Fudan University

  2. Institute of Nutrition, Fudan University

    Institute of Nutrition, Fudan University

  3. Medical College, Tarim University

    Medical College, Tarim University

  4. LaboHeal

    LaboHeal

Organized by

  1. Zhiyan Med

    Zhiyan Med

Supported by

  1. Shanghai Cancer Institute

    Shanghai Cancer Institute

  2. Huzhou University

    Huzhou University

Sponsored by

  1. BIOTIMES

    BIOTIMES

  2. Thermo Fisher Scientific Inc.

    Thermo Fisher Scientific Inc.

Media partner

  1. Wiley

    Wiley